0001731122-23-000097.txt : 20230130 0001731122-23-000097.hdr.sgml : 20230130 20230130142623 ACCESSION NUMBER: 0001731122-23-000097 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20230130 ITEM INFORMATION: Changes in Registrant's Certifying Accountant ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230130 DATE AS OF CHANGE: 20230130 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BioCrude Technologies USA, Inc. CENTRAL INDEX KEY: 0001690384 STANDARD INDUSTRIAL CLASSIFICATION: REFUSE SYSTEMS [4953] IRS NUMBER: 812924160 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-55818 FILM NUMBER: 23566956 BUSINESS ADDRESS: STREET 1: 1255 PHILLIPS SQUARE, SUITE 605 CITY: MONTREAL STATE: A8 ZIP: H3B 3G5 BUSINESS PHONE: 514-962-0070 MAIL ADDRESS: STREET 1: 1255 PHILLIPS SQUARE, SUITE 605 CITY: MONTREAL STATE: A8 ZIP: H3B 3G5 8-K 1 e4373_8k.htm FORM 8-K
0001690384 false 0001690384 2023-01-30 2023-01-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

U.S. SECURITIES AND EXCHANGE COMMISSION

 Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): January 30, 2023

 

BioCrude Technologies USA, Inc.

 (Exact Name of Registrant as Specified in its Charter)

  

 Nevada  000-55818 81-2924160
(State of incorporation)  Commission File Number (I.R.S. Employer Identification No.)

 

1255 Phillips Square, Suite 605
Montreal, QB, Canada H3B 3G5
(Address of principal executive offices)

 

514-840-9719
(Registrant’s telephone number including area code

 

Not Applicable
(former name or former address, if changed since last report)

  

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

  

 

   

ITEM 4.01. CHANGES IN REGISTRANT’S CERTIFYING ACCOUNTANT

 

(1)PREVIOUS INDEPENDENT AUDITORS:

 

  a. On January 27, 2023, the Company terminated BF Borgers, CPA PC (“BF Borgers”), situated at 5400 W Cedar Ave, Lakewood, CO, USA 80226 (Ph: 303-953-1454, Fax: 720-251-8836; Website: www.bfbcpa.us) as its registered independent public accountant.
     
  b. BF Borgers’ reports on the financial statements for the periods March 31, 2019, through December 31, 2022 (BF Borgers was hired March 14, 2019), contained no adverse opinion or disclaimer of opinion and was not qualified or modified as to audit scope or accounting, except that the report contained an explanatory paragraph stating that there was substantial doubt about the Company’s ability to continue as a going concern.
     
  c. Our Board of Directors participated in and approved the decision to change independent accountants. Through the reporting periods covered March 31, 2019, and September 30, 2022, there have been no disagreements with BF Borgers on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements if not resolved to the satisfaction of BF Borgers, would have caused them to make reference thereto, in their report on the financial statements. Throughout the interim engagement period, until the termination date, January 30, 2023, there have been no disagreements whatsoever with BF Borgers on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of BF Borgers would have caused them to make reference thereto in their report on the financial statements.
     
  d. We have authorized BF Borgers to respond fully to the inquiries of the successor accountant.
     
  e. During the periods March 31, 2019, through September 30, 2022, there have been no reportable events with us as set forth in Item 304(a)(1)(iv) of Regulation S-K.
     
  f. The Company provided a copy of the foregoing disclosures to BF Borgers prior to the date of the filing of this Report and requested that BF Borgers furnish it with a letter addressed to the Securities & Exchange Commission stating whether it agrees with the statements in this Report or not. A copy of such letter is filed as Exhibit 16.1 to this Form 8-K.

  

  (2) NEW INDEPENDENT ACCOUNTANTS:

 

a.On January 30, 2023, the Company engaged MAC Accounting Group, LLP (1070 Mecham Lane, Midvale, Utah 84047; Tel: (801) 414-3664) as its new registered independent public accountant.

 

b.During the periods of March 31, 2019, through December 31, 2022, we did not consult with MAC Accounting Group, LLP regarding:

 

  i. the application of accounting principles to a specified transaction,

 

  ii. the type of audit opinion that might be rendered on the Company’s financial statements by MAC Accounting Group, LLP, in either case, where written or oral advice provided by MAC Accounting Group, LLP would be an important factor considered by us in reaching a decision as to any accounting, auditing or financial reporting issues, or

 

  iii. any other matter that was the subject of a disagreement between us and our former auditor or was a reportable event (as described in Items 304(a)(1)(iv) or Item 304(a)(1)(v) of Regulation S-K, respectively).

 

 

 

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS

 

  d. Exhibits

  

Number Exhibit
16.1 Letter from BF Borgers dated January 30, 2023, regarding Change in Certifying Accountant

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  BIOCRUDE TECHNOLOGIES USA, INC.
   
Dated: January 30, 2023 /s/ John Moukas 
  Chief Executive Officer

 

 

 

 EX-16.1 2 e4373_ex16-1.htm EXHIBIT 16.1

 

 

EXHIBIT 16.1

  

January 30, 2023

 

United States Securities and Exchange Commission

Office of the Chief Accountant

100 F Street, N.E.

Washington, D.C.  20549

 

Re: BioCrude Technologies USA, Inc.

 

Ladies and Gentleman:

 

We have read the statements under item 4.01 in the Form 8-K dated January 30, 2023, of BioCrude Technologies USA, Inc. (the “Company”) to be filed with the Securities and Exchange Commission and we agree with such statements therein as related to our firm. We have no basis to, and therefore, do not agree or disagree with the other statements made by the Company in the Form 8-K.

 

Sincerely,

 

 

BF Borgers CPA PC

Certified Public Accountants

Lakewood, CO

  

 

 

 

 EX-101.SCH 3 biocrudetechcom-20230130.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 biocrudetechcom-20230130_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 biocrudetechcom-20230130_pre.xml XBRL PRESENTATION FILE GRAPHIC 6 image_001.jpg GRAPHIC begin 644 image_001.jpg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end XML 7 R1.htm IDEA: XBRL DOCUMENT v3.22.4
Cover
Jan. 30, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jan. 30, 2023
Entity File Number 000-55818
Entity Registrant Name BioCrude Technologies USA, Inc.
Entity Central Index Key 0001690384
Entity Tax Identification Number 81-2924160
Entity Incorporation, State or Country Code NV
Entity Address, Address Line One 1255 Phillips Square
Entity Address, Address Line Two Suite 605
Entity Address, Address Line Three Montreal
Entity Address, City or Town QB
Entity Address, Country CA
Entity Address, Postal Zip Code H3B 3G5
City Area Code 514
Local Phone Number 840-9719
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
XML 8 e4373_8k_htm.xml IDEA: XBRL DOCUMENT 0001690384 2023-01-30 2023-01-30 iso4217:USD shares iso4217:USD shares 0001690384 false 8-K 2023-01-30 BioCrude Technologies USA, Inc. NV 000-55818 81-2924160 1255 Phillips Square Suite 605 Montreal QB CA H3B 3G5 514 840-9719 false false false false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.4 html 1 20 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://biocrudetech.com/role/Cover Cover Cover 1 false false All Reports Book All Reports [dq-0540-EntityEmergingGrowthCompany-Missing] Submission type 8-K should have a non-empty value for EntityEmergingGrowthCompany in the Required Context. e4373_8k.htm e4373_8k.htm biocrudetechcom-20230130.xsd biocrudetechcom-20230130_lab.xml biocrudetechcom-20230130_pre.xml e4373_ex16-1.htm http://xbrl.sec.gov/dei/2022 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "e4373_8k.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 20 }, "contextCount": 1, "dts": { "inline": { "local": [ "e4373_8k.htm" ] }, "labelLink": { "local": [ "biocrudetechcom-20230130_lab.xml" ] }, "presentationLink": { "local": [ "biocrudetechcom-20230130_pre.xml" ] }, "schema": { "local": [ "biocrudetechcom-20230130.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 59, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 20, "memberCustom": 0, "memberStandard": 0, "nsprefix": "biocrudetechcom", "nsuri": "http://biocrudetech.com/20230130", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "e4373_8k.htm", "contextRef": "From2023-01-30to2023-01-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://biocrudetech.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "e4373_8k.htm", "contextRef": "From2023-01-30to2023-01-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biocrudetech.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r10": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r11": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r12": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r13": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r14": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r15": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r18": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r19": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r9": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 16 0001731122-23-000097-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001731122-23-000097-xbrl.zip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end